Protein Mitch Reprograms Fat Metabolism, Hinting at Next-Gen Obesity Therapies

Researchers at the Weizmann Institute identified MTCH2, nicknamed Mitch, as a key regulator of fat fate and energy use. Blocking Mitch in muscle and precursor fat cells drives increased fat oxidation and suppresses new fat-cell formation, and mice lacking Mitch stayed lean with more muscle and improved heart function. The findings suggest a potential obesity treatment that boosts fat burning while preserving muscle, though human therapies are not yet available and further research is needed.